SCHEMBL31719787

SCHEMBL31719787

COC(=O)c1cc(F)cc(C)c1Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.41
SLC6A3 Q01959 2/20 0.39
SLC6A4 P31645 1/20 0.39
NPC1 O15118 1/20 0.39
CASP3 P42574 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
MAPT P10636 2/20 0.38
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA7 P43166 2/20 0.37
CA9 Q16790 2/20 0.37
CA14 Q9ULX7 2/20 0.37
PDK2 Q15119 1/20 0.37
PDK4 Q16654 1/20 0.37
NR4A2 P43354 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28406632 0.84 CES2 (0.42) SOS1SLC6A3SLC6A4NPC1CASP3
SCHEMBL28474614 0.82 SOS1 (0.41) SOS1SLC6A3SLC6A4NPC1CASP3
SCHEMBL14719381 0.81 SLC6A4 (0.41) SOS1SLC6A3SLC6A4NPC1CASP3
SCHEMBL1422048 0.81 SLC6A4 (0.41) SOS1SLC6A3SLC6A4NPC1CASP3
SCHEMBL28601825 0.81 XDH (0.41) MAPTCA12CA1CA2CA7
SCHEMBL1636595 0.81 KDM4E (0.43) SLC6A3NPC1RAB9AMAPTCA12
SCHEMBL15067775 0.81 KDM4E (0.46) SOS1SLC6A3SLC6A4MAPTCA12
SCHEMBL23599863 0.80 CYP3A4 (0.53) NPC1SMN1; SMN2MAPTCA12CA1
SCHEMBL23302512 0.80 CA12 (0.42) SLC6A3SLC6A4NPC1CASP3RAB9A
SCHEMBL851848 0.79 KEAP1 (0.41) KDM4ENOTUMTSHRGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250340516-A1 Isoquinolinones as Modulators of POLRMT PRETZEL THERAPEUTICS, INC. (US) 2025-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250340516-A1 Isoquinolinones as Modulators of POLRMT POLRMT, TFAM, UQCRC1 SOS1 4733/4885SLC6A3 3866/4885SLC6A4 3187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.